Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women
- PMID: 10459558
- DOI: 10.1016/s0026-0495(99)90190-7
Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women
Abstract
Leptin, the satiety hormone expressed almost exclusively in adipose tissue, is a marker of body fat accumulation in humans. Recent studies have shown that plasminogen activator inhibitor-1 (PAI-1), a prothrombotic factor associated with atherosclerosis complications, is also produced in adipose tissue. The objective of the present study was to determine whether PAI-1 antigen plasma concentrations are associated with leptin plasma levels or the body fat mass (FM) independently of the variables known to influence PAI-1 production. Sixty-one nondiabetic women aged 18 to 45 years with a wide range of values for the body mass index ([BMI] 18.1 to 37.7 kg/m2) were evaluated for (1) body FM and fasting plasma levels of (2) PAI-1 antigen, (3) PAI-1 activity, (4) leptin, (5) insulin, (6) blood glucose, and (7) lipids (cholesterol, high-density lipoprotein [HDL]-cholesterol, and triglycerides [TG]). Body FM and fat-free mass (FFM) were estimated during fasting conditions by the bioimpedance analysis (BIA) method using a tetrapolar device. Body fat distribution was evaluated by the waist circumference and the waist to hip ratio (WHR). FM was directly associated with both PAI-1 antigen (r = .585, P < .001) and PAI-1 activity (r = .339, P < .001). Seemingly, leptin was positively related to both PAI-1 antigen (r = .630, P < .001) and PAI-1 activity (r = .497, P < .001). Moreover, both PAI-I antigen and PAI-1 activity were directly correlated with FFM (r = .285, P < .05, and r = .336, P < .01, respectively), BMI (r = .594, P < .001, and r = .458, P < .001, respectively), and WHR (r = .510, P < .001, and r = .391, P < .005, respectively). Insulin was directly related to PAI-1 antigen (r = .540, P < .001), PAI-1 activity (r = .259, P < .05), leptin (r = .447, P < .001), and FM (r = .435, P < .001). The association between PAI-1 antigen (dependent variable) and leptin or FM was tested by a stepwise regression model simultaneously including leptin, FM, BMI, WHR, age, FFM, and fasting insulin, blood glucose, TG, cholesterol, and HDL-cholesterol as independent variables. PAI-1 antigen maintained a significant positive independent relationship only with leptin (t = 2.923, P < .01), insulin (t = 3.489, P < .001), and fasting blood glucose (t = 2.092, P < .05), and a negative independent relationship with HDL-cholesterol (t = -2.634, P < .05). In conclusion, the strong relationship between PAI-1 antigen and leptin irrespective of other variables known to influence these factors seems to indicate that leptin per se may potentially increase PAI-1 plasma concentrations in obese subjects.
Similar articles
-
Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.Metabolism. 1997 Nov;46(11):1287-93. doi: 10.1016/s0026-0495(97)90232-8. Metabolism. 1997. PMID: 9361687
-
Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution.Int J Obes Relat Metab Disord. 1997 Jul;21(7):527-535. doi: 10.1038/sj.ijo.0800435. Int J Obes Relat Metab Disord. 1997. PMID: 9226481
-
Hemostatic variables, carbohydrate metabolism and lipid profile in women with low body mass index.Gynecol Endocrinol. 2003 Apr;17(2):151-7. doi: 10.1080/gye.17.2.151.157. Gynecol Endocrinol. 2003. PMID: 12744226
-
Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance.Diabetes Metab Res Rev. 2000 May-Jun;16(3):192-201. doi: 10.1002/1520-7560(200005/06)16:3<192::aid-dmrr114>3.0.co;2-g. Diabetes Metab Res Rev. 2000. PMID: 10867719 Review.
-
Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus.Ann Med. 1996 Aug;28(4):371-80. doi: 10.3109/07853899608999095. Ann Med. 1996. PMID: 8862693 Review.
Cited by
-
Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.J Am Coll Cardiol. 2008 Oct 7;52(15):1201-10. doi: 10.1016/j.jacc.2008.05.060. J Am Coll Cardiol. 2008. PMID: 18926322 Free PMC article. Review.
-
Moderate rest intervals are superior to short intervals for improving PAI-1 following exhaustive exercise in recreational weightlifters.J Exerc Rehabil. 2016 Dec 31;12(6):559-566. doi: 10.12965/jer.1632788.394. eCollection 2016 Dec. J Exerc Rehabil. 2016. PMID: 28119878 Free PMC article.
-
Leptin links with plasminogen activator inhibitor-1 in human obesity: the SABPA study.Hypertens Res. 2015 Jul;38(7):507-12. doi: 10.1038/hr.2015.28. Epub 2015 Mar 5. Hypertens Res. 2015. PMID: 25740294
-
The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance.Scientifica (Cairo). 2012;2012:525374. doi: 10.6064/2012/525374. Epub 2012 Aug 30. Scientifica (Cairo). 2012. PMID: 24278711 Free PMC article. Review.
-
Leptin in inflammation and autoimmunity.Cytokine. 2017 Oct;98:51-58. doi: 10.1016/j.cyto.2016.10.011. Cytokine. 2017. PMID: 27916613 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous